A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.
Saved in:
| Title: | A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals. |
|---|---|
| Authors: | Vergouwe M; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases., Biemond JJ; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases., van der Straten K; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., van Pul L; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kerster G; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Claireaux M; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Burger JA; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., van Dort KA; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kootstra NA; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Jonges M; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Welkers MRA; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Hazenberg MD; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., Peters-Sengers H; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans., van Gils MJ; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Birnie E; Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, location AMC, University of Amsterdam, Amsterdam, The Netherlans.; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., de Bree GJ; Amsterdam institute for Infection and Immunity, Infectious Diseases.; Division of Infectious Diseases, Department of Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands. |
| Corporate Authors: | TURN-COVID study group |
| Source: | The Journal of infectious diseases [J Infect Dis] 2024 Oct 16; Vol. 230 (4), pp. e860-e871. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiae306 |
